Mohawk posts FY 2025 net earnings attributable to Mohawk Industries, Inc. of USD 369.9 million (down 28.1%)

Reuters
02/24
Mohawk posts FY 2025 net earnings attributable to Mohawk Industries, Inc. of USD 369.9 million (down 28.1%)

Mohawk reported FY 2025 net sales of USD 10.8 billion (down 0.5%), with gross profit of USD 2.6 billion and operating income of USD 489.8 million. Net earnings attributable to shareholders were USD 369.9 million, while cash from operating activities totaled USD 1.1 billion and cash and cash equivalents were USD 856.1 million at Dec. 31, 2025. The company said it reduced FY 2025 capital expenditures to USD 440 million and plans to invest about USD 480 million in 2026, and noted cumulative restructuring actions initiated since 2022 are expected to deliver annualized benefits of about USD 365 million, with recent overhead and asset-exit initiatives expected to generate about USD 30 million in annual savings upon completion. Mohawk also highlighted actions taken during 2025 to support demand, including new product launches, targeted marketing and promotional programs, and noted it is monitoring tariff developments and geopolitical risks related to its global footprint, including operations in Russia.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mohawk Industries Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000851968-26-000011), on February 24, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10